Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 27, 2010
- Accepted after revision December 2, 2010
- Published online August 12, 2011.
Copyright & Usage
Copyright © American Society of Neuroradiology
Author Information
- A. Guptaa,
- R.J. Younga,b,
- S. Karimia,b,
- S. Sooda,
- Z. Zhangd,
- Q. Mod,
- P.H. Gutinb,c,
- A.I. Holodnya,b and
- A.B. Lassmanb,e
- aFrom the Department of Radiology (A.G., R.J.Y., S.K., S.S., A.I.H.)
- bBrain Tumor Center (R.J.Y., S.K., P.H.G., A.I.H., A.B.L.)
- cDepartments of Neurosurgery (P.H.G.)
- dEpidemiology and Biostatistics (Z.Z., Q.M.)
- eNeurology (A.B.L.), Memorial Sloan-Kettering Cancer Center, New York, New York.
- Please address correspondence to Robert J. Young, MD, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, MRI-1156, New York, NY 10065; e-mail: youngr{at}mskcc.org
Altmetrics
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research
- Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma
- Lessons From Anti-Vascular Endothelial Growth Factor and Anti-Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma
- Advanced Magnetic Resonance Imaging of the Physical Processes in Human Glioblastoma
- Potential Role of Preoperative Conventional MRI Including Diffusion Measurements in Assessing Epidermal Growth Factor Receptor Gene Amplification Status in Patients with Glioblastoma
- Correlation of MRI-Derived Apparent Diffusion Coefficients in Newly Diagnosed Gliomas with [18F]-Fluoro-L-Dopa PET: What Are We Really Measuring with Minimum ADC?
- Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas Are Associated with Improved Survival Compared with Matched Controls